Oscar Health Raises 2026 Operating Earnings Outlook as Margins Improve

Oscar Health (OSCR) lifted its 2026 operating earnings guidance to $500M-$700M, up from the prior $250M-$450M range. The raise doubles the low end of the outlook and adds $250M to the top end.

The driver is margin repair. OSCR's medical loss ratio improved to 75% from 83%, an eight-point swing. Management also credited disciplined pricing and technology-driven expense efficiency for the stronger profit trajectory.

Revenue guidance did not move, holding at $18.7B-$19B. Interpretation: with the top line unchanged, the entire guidance upgrade rests on profitability, not growth, so the market will focus on whether the 75% loss ratio holds.

The company flagged second-half headwinds. Monthly churn runs 2%-4%, medical costs are rising, and open-enrollment spending will weigh on results. Interpretation: the raised range likely embeds these pressures, but any deterioration in the loss ratio would hit the margin story that justifies the higher outlook.

No peer guidance changes are cited in the source for ELV or UNH. Interpretation: traders may still read OSCR's margin recovery against those large managed-care names, since loss-ratio trends are the shared profit lever across the group.